BRAF, MEK1, AKT1 testing by a new diagnostic method to detect point mutations associated with melanoma: CLART CMA BRAF-MEK1-AKT1.

e21074Background: The mitogen-activated protein kinase (MAPK) pathway can be constitutively activated by alterations in specific genes in many cancers. BRAF mutations have been identified approxima...